Global Vertigo Drugs Market 2023-2027

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global vertigo drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global vertigo drugs market market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Peripheral vertigo - Market size and forecast 2022-2027
Exhibit 34: Chart on Peripheral vertigo - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Peripheral vertigo - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Peripheral vertigo - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Peripheral vertigo - Year-over-year growth 2022-2027 (%)
6.4 Central vertigo - Market size and forecast 2022-2027
Exhibit 38: Chart on Central vertigo - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Central vertigo - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Central vertigo - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Central vertigo - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)
Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 46: Chart on Comparison by Distribution Channel
Exhibit 47: Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2022-2027
Exhibit 48: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Offline - Year-over-year growth 2022-2027 (%)
7.4 Online - Market size and forecast 2022-2027
Exhibit 52: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Online - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Distribution Channel
Exhibit 56: Market opportunity by Distribution Channel ($ million)
Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Altamira Therapeutics Ltd.
Exhibit 107: Altamira Therapeutics Ltd. - Overview
Exhibit 108: Altamira Therapeutics Ltd. - Product/Service
Exhibit 109: Altamira Therapeutics Ltd. - Key offerings
12.4 Amneal Pharmaceuticals Inc.
Exhibit 110: Amneal Pharmaceuticals Inc. - Overview
Exhibit 111: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 112: Amneal Pharmaceuticals Inc. - Key news
Exhibit 113: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 114: Amneal Pharmaceuticals Inc. - Segment focus
12.5 Endo International Plc
Exhibit 115: Endo International Plc - Overview
Exhibit 116: Endo International Plc - Business segments
Exhibit 117: Endo International Plc - Key news
Exhibit 118: Endo International Plc - Key offerings
Exhibit 119: Endo International Plc - Segment focus
12.6 Epic Pharma LLC
Exhibit 120: Epic Pharma LLC - Overview
Exhibit 121: Epic Pharma LLC - Product/Service
Exhibit 122: Epic Pharma LLC - Key offerings
12.7 F. Hoffmann La Roche Ltd.
Exhibit 123: F. Hoffmann La Roche Ltd. - Overview
Exhibit 124: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 125: F. Hoffmann La Roche Ltd. - Key news
Exhibit 126: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 127: F. Hoffmann La Roche Ltd. - Segment focus
12.8 GlaxoSmithKline Plc
Exhibit 128: GlaxoSmithKline Plc - Overview
Exhibit 129: GlaxoSmithKline Plc - Business segments
Exhibit 130: GlaxoSmithKline Plc - Key news
Exhibit 131: GlaxoSmithKline Plc - Key offerings
Exhibit 132: GlaxoSmithKline Plc - Segment focus
12.9 Indicus Pharma
Exhibit 133: Indicus Pharma - Overview
Exhibit 134: Indicus Pharma - Product/Service
Exhibit 135: Indicus Pharma - Key offerings
12.10 Jubilant Pharmova Ltd.
Exhibit 136: Jubilant Pharmova Ltd. - Overview
Exhibit 137: Jubilant Pharmova Ltd. - Business segments
Exhibit 138: Jubilant Pharmova Ltd. - Key news
Exhibit 139: Jubilant Pharmova Ltd. - Key offerings
Exhibit 140: Jubilant Pharmova Ltd. - Segment focus
12.11 Novartis AG
Exhibit 141: Novartis AG - Overview
Exhibit 142: Novartis AG - Business segments
Exhibit 143: Novartis AG - Key offerings
Exhibit 144: Novartis AG - Segment focus
12.12 Pfizer Inc.
Exhibit 145: Pfizer Inc. - Overview
Exhibit 146: Pfizer Inc. - Product/Service
Exhibit 147: Pfizer Inc. - Key news
Exhibit 148: Pfizer Inc. - Key offerings
12.13 Sensorion
Exhibit 149: Sensorion - Overview
Exhibit 150: Sensorion - Product/Service
Exhibit 151: Sensorion - Key offerings
12.14 Sun Pharmaceutical Industries Ltd.
Exhibit 152: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 153: Sun Pharmaceutical Industries Ltd. - Product/Service
Exhibit 154: Sun Pharmaceutical Industries Ltd. - Key offerings
12.15 Suven Life Sciences Ltd.
Exhibit 155: Suven Life Sciences Ltd. - Overview
Exhibit 156: Suven Life Sciences Ltd. - Product/Service
Exhibit 157: Suven Life Sciences Ltd. - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 158: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 159: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 160: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 161: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 162: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Viatris Inc.
Exhibit 163: Viatris Inc. - Overview
Exhibit 164: Viatris Inc. - Business segments
Exhibit 165: Viatris Inc. - Key news
Exhibit 166: Viatris Inc. - Key offerings
Exhibit 167: Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 168: Inclusions checklist
Exhibit 169: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 170: Currency conversion rates for US$
13.4 Research methodology
Exhibit 171: Research methodology
Exhibit 172: Validation techniques employed for market sizing
Exhibit 173: Information sources
13.5 List of abbreviations
Exhibit 174: List of abbreviations

List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global vertigo drugs market market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Type - Market share 2022-2027 (%)
Exhibits 31: Data Table on Type - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Peripheral vertigo - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Peripheral vertigo - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Peripheral vertigo - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Peripheral vertigo - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Central vertigo - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Central vertigo - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Central vertigo - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Central vertigo - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Type ($ million)
Exhibits 43: Data Table on Market opportunity by Type ($ million)
Exhibits 44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits 46: Chart on Comparison by Distribution Channel
Exhibits 47: Data Table on Comparison by Distribution Channel
Exhibits 48: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits 50: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits 51: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits 52: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits 56: Market opportunity by Distribution Channel ($ million)
Exhibits 57: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 61: Chart on Geographic comparison
Exhibits 62: Data Table on Geographic comparison
Exhibits 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 99: Market opportunity By Geographical Landscape ($ million)
Exhibits 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 101: Impact of drivers and challenges in 2022 and 2027
Exhibits 102: Overview on Criticality of inputs and Factors of differentiation
Exhibits 103: Overview on factors of disruption
Exhibits 104: Impact of key risks on business
Exhibits 105: Vendors covered
Exhibits 106: Matrix on vendor position and classification
Exhibits 107: Altamira Therapeutics Ltd. - Overview
Exhibits 108: Altamira Therapeutics Ltd. - Product/Service
Exhibits 109: Altamira Therapeutics Ltd. - Key offerings
Exhibits 110: Amneal Pharmaceuticals Inc. - Overview
Exhibits 111: Amneal Pharmaceuticals Inc. - Business segments
Exhibits 112: Amneal Pharmaceuticals Inc. - Key news
Exhibits 113: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits 114: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits 115: Endo International Plc - Overview
Exhibits 116: Endo International Plc - Business segments
Exhibits 117: Endo International Plc - Key news
Exhibits 118: Endo International Plc - Key offerings
Exhibits 119: Endo International Plc - Segment focus
Exhibits 120: Epic Pharma LLC - Overview
Exhibits 121: Epic Pharma LLC - Product/Service
Exhibits 122: Epic Pharma LLC - Key offerings
Exhibits 123: F. Hoffmann La Roche Ltd. - Overview
Exhibits 124: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 125: F. Hoffmann La Roche Ltd. - Key news
Exhibits 126: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 127: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 128: GlaxoSmithKline Plc - Overview
Exhibits 129: GlaxoSmithKline Plc - Business segments
Exhibits 130: GlaxoSmithKline Plc - Key news
Exhibits 131: GlaxoSmithKline Plc - Key offerings
Exhibits 132: GlaxoSmithKline Plc - Segment focus
Exhibits 133: Indicus Pharma - Overview
Exhibits 134: Indicus Pharma - Product/Service
Exhibits 135: Indicus Pharma - Key offerings
Exhibits 136: Jubilant Pharmova Ltd. - Overview
Exhibits 137: Jubilant Pharmova Ltd. - Business segments
Exhibits 138: Jubilant Pharmova Ltd. - Key news
Exhibits 139: Jubilant Pharmova Ltd. - Key offerings
Exhibits 140: Jubilant Pharmova Ltd. - Segment focus
Exhibits 141: Novartis AG - Overview
Exhibits 142: Novartis AG - Business segments
Exhibits 143: Novartis AG - Key offerings
Exhibits 144: Novartis AG - Segment focus
Exhibits 145: Pfizer Inc. - Overview
Exhibits 146: Pfizer Inc. - Product/Service
Exhibits 147: Pfizer Inc. - Key news
Exhibits 148: Pfizer Inc. - Key offerings
Exhibits 149: Sensorion - Overview
Exhibits 150: Sensorion - Product/Service
Exhibits 151: Sensorion - Key offerings
Exhibits 152: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 153: Sun Pharmaceutical Industries Ltd. - Product/Service
Exhibits 154: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 155: Suven Life Sciences Ltd. - Overview
Exhibits 156: Suven Life Sciences Ltd. - Product/Service
Exhibits 157: Suven Life Sciences Ltd. - Key offerings
Exhibits 158: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 159: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 160: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 161: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 162: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 163: Viatris Inc. - Overview
Exhibits 164: Viatris Inc. - Business segments
Exhibits 165: Viatris Inc. - Key news
Exhibits 166: Viatris Inc. - Key offerings
Exhibits 167: Viatris Inc. - Segment focus
Exhibits 168: Inclusions checklist
Exhibits 169: Exclusions checklist
Exhibits 170: Currency conversion rates for US$
Exhibits 171: Research methodology
Exhibits 172: Validation techniques employed for market sizing
Exhibits 173: Information sources
Exhibits 174: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global vertigo drugs market: AdvaCare Pharma, Altamira Therapeutics Ltd., Amneal Pharmaceuticals Inc., Endo International Plc, Epic Pharma LLC, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Indicus Pharma, Intas Pharmaceuticals Ltd., Jubilant Pharmova Ltd., Lupin Ltd., Novartis AG, Otonomy Inc., Pfizer Inc., Sensorion, Sound Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Suven Life Sciences Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is integration of digital health solutions in vertigo.'

According to the report, one of the major drivers for this market is the rising demand for vertigo drugs in emerging economies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

• AdvaCare Pharma
• Altamira Therapeutics Ltd.
• Amneal Pharmaceuticals Inc.
• Endo International Plc
• Epic Pharma LLC
• F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Plc
• Indicus Pharma
• Intas Pharmaceuticals Ltd.
• Jubilant Pharmova Ltd.
• Lupin Ltd.
• Novartis AG
• Otonomy Inc.
• Pfizer Inc.
• Sensorion
• Sound Pharmaceuticals
• Sun Pharmaceutical Industries Ltd.
• Suven Life Sciences Ltd.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.